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Abstract
Background: Baculovirus, which has a width of 40 nm and a length of 250-300 nm, can display functional
peptides, receptors and antigens on its surface by their fusion with a baculovirus envelop protein, GP64. In
addition, some transmembrane proteins can be displayed without GP64 fusion, using the native transmembrane
domains of the baculovirus. We used this functionality to display human prorenin receptor fused with GFPuv
(GFPuv-hPRR) on the surface of silkworm Bombyx mori nucleopolyhedrovirus (BmNPV) and then tested whether
these baculovirus particles could be used to detect protein-protein interactions.
Results: BmNPV displaying GFPuv-hPRR (BmNPV-GFPuv-hPRR) was purified from hemolymph by using Sephacryl S-
1000 column chromatography in the presence of 0.01% Triton X-100. Its recovery was 86% and the final
baculovirus particles number was 4.98 × 108 pfu. Based on the results of enzyme-linked immunosorbent assay
(ELISA), 3.1% of the total proteins in BmNPV-GFPuv-hPRR were GFPuv-hPRR. This value was similar to that calculated
from the result of western blot by a densitometry (2.7%). To determine whether BmNPV-GFPuv-hPRR particles were
bound to human prorenin, ELISA results were compared with those from ELISAs using protease negative BmNPV
displaying b1,3-N-acetylglucosaminyltransferase 2 fused with the gene encoding GFPuv (GGT2) (BmNPV-CP
--GGT2)
particles, which do not display hPRR on their surfaces.
Conclusion: The display of on the surface of the BmNPV particles will be useful for the detection of protein-
protein interactions and the screening of inhibitors and drugs in their roles as nanobioparticles.
Keywords: BmNPV human prorenin receptor, silkworm, display, ELISA
Background
Baculovirus has been used widely to express recombi-
nant proteins in insect cells and larvae [1,2]. Autographa
californica multiple nucleopolyhedrovirus (AcMNPV)
has been the most commonly used baculovirus for
recombinant protein production [3]. Baculovirus infec-
tion can be divided to three distinct phases, early, late
and very late phase. While budding virus (BV) is pro-
duced in the late phase, the occlusion derived virus
(ODV) form is produced in the very late phase. The BV
form has a width of 40 nm and a length of 250-300 nm
[4] has been used as a nanoparticle [5,6] in a baculo-
virus surface displaying system. ODV form can also be
used as nanoparticles, because ODV-polyhedrin particles
are resistant to heat and light inactivation, whereas BV
is more sensitive to environment. Cultured insect cells
are used to produce and amplify recombinant AcMNPV,
which means that large-scale cultivation of insect cells is
also needed to produce recombinant baculovirus parti-
cles. By contrast, silkworm Bombyx mori nucleopolyhe-
drovirus (BmNPV) was recently used for the large-scale
production of recombinant proteins and baculovirus
particles owing to its ability to infect silkworm larvae
and pupae [2]. Silkworms can rapidly produce a high
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level of recombinant proteins and baculovirus particles
with BmNPV bacmids [7,8]. For example, ~2.2 mg of
purified human a2,6-sialyltransferase was obtained from
only 11 silkworm larvae injected with recombinant bac-
mid harboring a2,6-sialyltransferase gene [9]. Predicted
amino acid sequences of corresponding ORFs of
BmNPV are closely related to those of AcMNPV (~90%
relatedness) [10].
Once established, the baculovirus display system can
be used to produce baculoviruses displaying functional
peptides, receptors and antigens that enable the delivery
of heterologous gene expression in mammalian cells and
tissues, as well as the production of antibodies and vac-
cines [11-13]. Baculovirus has an envelope protein
(GP64) that comprises an N-terminal signal peptide, a
mature domain, a transmembrane domain and a short
cytoplasmic domain at its C-terminus. Heterogeneous
peptides and proteins can be displayed on the surface of
baculovirus envelope by fusion with either the full-
length GP64 or its transmembrane and cytoplasmic
domains [14]. Some transmembrane proteins can be
also displayed on the surface of baculovirus without fus-
ing with any domain [15,16]. Several enzymes and
receptors can be displayed with its native form [17] and
receptor-displaying baculoviruses are used for specific
protein-protein interaction detection and the expression
cloning of CD2 cDNA from cDNA expression libraries
by magnetic separation. As an alternative baculovirus
display system, baculovirus capsid display has been also
established by fusion with a nucleocapsid protein, VP39,
for transduction imaging [18]. The baculovirus display
system is also becoming more important in the life
sciences as an addition to the baculovirus expression
system.
Recently, many studies have reported that human pro-
renin receptor (hPRR), and its mechanism of binding to
renin/prorenin, involves the generation or action of
angiotensin, leading to numerous cardiovascular diseases
[19-21]. Consequently, the development of hPRR recep-
tor blockers is currently receiving considerable attention.
Also, an understanding of the functional properties of
hPRR through detailed biochemical and biophysical ana-
lysis is required. In a previous study, hPRR fused with
GFPuv at its N-terminus (GFPuv-hPRR) was expressed
and purified from the fat body of silkworm larvae
infected with recombinant baculovirus [22,23]. However,
the binding capacity of purified GFPuv-hPRR to human
prorenin was reduced compared with that before purifi-
cation. Possible reasons might be that the protein struc-
ture is broken or that the recognition sites become
buried inside the molecule during purification. In the
current study, we attempted to display GFPuv-hPRR on
the surface of BmNPV and to purify the baculovirus
particles from silkworm larval hemolymph using
size-exclusion chromatography (SEC). Purified baculo-
virus particles were characterized and used to detect the
interaction of GFPuv-hPRR and human prorenin by an
enzyme-linked immunosorbent assay (ELISA).
Results
Improvement of purification efficiency of BmNPV particles
As detailed in a previous report [8], hPRR-displayed
BmNPV (BmNPV-hPRR) was produced in silkworm lar-
vae and purified by SEC. Its SEC recovery efficiency was
~35% and decreased by 4% with ultracentrifugation to
concentrate the baculovirus particles. Final BmNPV par-
ticle concentration was 1.6 × 108 pfu ml-1 [8]. In the
current study, BmNPV-GFPuv-hPRR was produced and
purified using the same methods as detailed in [8].
GFPuv-hPRR was detected in purified BmNPV-GFPuv-
hPRR particles, but not in purified protease negative
BmNPV-CP--GGT2 particles, which harbor the gene
encoding human b1,3-N-acetylglucosaminyltransferase 2
fused with the gene encoding GFPuv (GGT2) instead of
the gene encoding GFPuv-hPRR (Figure 1) [24]. The
faint band (~65 kDa) found on analysis of the purified
BmNPV-CP--GGT2 particles is likely to represent an, as
yet, unspecified molecule. This kind of band could
sometimes be detected using anti-FLAG. The estimated
molecular weight of the GFPuv-GGT2 fusion protein is
~77 kDa, larger than that of GFPuv-hPRR (69 kDa), indi-
cating this band is not derived from GGT2. Recovery of
BmNPV-GFPuv-hPRR particles was 29% using SEC.
To improve the recovery efficiency of BmNPV-GFPuv-
hPRR, BmNPV-GFPuv-hPRR particles were suspended
with PBS containing 0.01% each of the detergents Triton
X-100, Tween 20 and PF-68, after ultracentrifugation.
Using purification, the recovery efficiency of baculovirus
particles was 0.9% without detergent. Using PBS con-
taining 0.01% of each detergent as a suspension buffer
Figure 1 GFPuv-hPRR in purified BmNPV-GFPuv-hPRR particles.
Proteins were separated by a 12% SDS-PAGE gel and GFPuv-hPRR
was detected by Western blot. Lane 1: purified BmNPV-GFPuv-hPRR
particles; lane 2: purified BmNPV-CP--GGT2 particles.
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after ultracentrifugation, particle purity and the recovery
efficiency improved. For example, when PF-68 was used
purity was increased higher 1000 times to that of hemo-
lymph, but recovery efficiency was low (1.4%). Using
Triton X-100 the recovery ratio was approximately ten
times more than for PBS alone and particle purity was
475 times more than that of hemolymph (Table 1).
Sephacryl S-1000 chromatography was then performed
using PBS containing each concentration (0.01 or 0.1%)
of Triton X-100 or Tween 20. The recovery efficiency of
BmNPV-GFPuv-hPRR particles was improved in the pre-
sence of detergent. For example, in the presence of
0.01% Triton X-100, its efficiency was 86%, which was
threefold more than using PBS alone (Table 2).
However, its recovery efficiency decreased in the pre-
sence of 0.1% Triton X-100, which indicates that a high
detergent concentration was deleterious to BmNPV par-
ticles. To confirm this effect, purified BmNPV particles
were treated with each concentration (0.01, 0.1 and 1%)
of Triton X-100. In the presence of 1% Triton X-100,
GFPuv-hPRR amount in the pellet fraction was lower
than that of 0.01 or 0.1% treatment (Figure 2). Proteins
were solubilized less under the 0.01% TritonX-100 treat-
ment compared with the 0.1% or 1% Triton X-100 treat-
ment. However, as the concentration of Triton X-100
was increased, more amounts of GP64 and other pro-
teins were solubilized into the supernatant fraction. It
was previously reported that GFPuv-hPRR was not solu-
bilized from the microsome fraction of silkworm fat
body efficiently by Triton X-100 [23]. Considering the
result of Table 2 0.01% TritonX-100 treatment are
milder to baculovirus envelope than 0.1% or 1% Triton
X-100 treatment.
Confirmation of surface display of GFPuv-hPRR on the
BmNPV particles with proteinase K
To confirm the surface display of GFPuv-hPRR on the
BmNPV particles, purified BmNPV-GFPuv-hPRR parti-
cles were treated with proteinase K (0.002, 0.02, 0.2 and
2 μg). If GFPuv-hPRR was displayed on the surface of
the BmNPV particles, it would be degraded by a less
amount of proteinase K than would the VP39 protein,
which is a nucleocapsid protein localized inside BmNPV
particles. In the presence of 0.02 μg proteinase K, VP39
was detected, but hPRR was not (Figure 3), suggesting
that displayed GFPuv-hPRR on the surface of BmNPV
particles had been degraded. In the presence of 0.2 or 2
μg of proteinase K, hPRR and VP39 were both degraded.
Quantification of GFPuv-hPRR displayed on the surface of
BmNPV particles
To quantify GFPuv-hPRR displayed on the surface of
BmNPV particles, an ELISA technique was used.
BmNPV-GFPuv-hPRR particles were immobilized in the
wells and hPRR was detected by ELISA (Figure 4A).
BmNPV-CP--GGT2, which does not display hPRR on
the surface of BmNPV particles, was used as a negative
control. First, hPRR purified from insect cells [25] was
used as a standard and a calibration curve of hPRR was
made. A liner relationship was observed between 0 and
Table 1 Purification of BmNPV-GFPuv-hPRR particles by Sephacryl S-1000 column chromatography
Volume (ml) Titer (pfu ml-1) Virus (pfu) Protein (mg ml-1) Purity (pfu mg-1 protein) Recovery (%)
Hemolymph 7 2.38 × 108 1.67 × 109 37.3 6.38 × 106 (1) 100
Sephacryl S-1000 chromatography 30 1.67 × 107 4.86 × 108 0.011 1.52 × 109 (238) 29
After ultracentrifugation
Suspended with PBS 0.5 2.97 × 107 1.49 × 107 0.111 2.68 × 108 (42) 0.9
Suspended with 0.01% Triton X-100 0.5 3.33 × 108 1.66 × 108 0.110 3.03 × 109 (475) 10
Suspended with 0.01% Tween 20 0.5 1.51 × 108 7.55 × 107 0.071 2.13 × 109 (334) 4.5
Suspended with 0.01% PF-68 0.5 4.60 × 108 2.30 × 107 0.059 7.80 × 109 (1,222) 1.4
Table 2 Purification of BmNPV-GFPuv-hPRR particles by Sephacryl S-1000 column chromatography with detergent-
containing PBS
Volume (ml) Titer (pfu ml-1) Virus (pfu) Recovery (%)
Hemolymph 7 2.38 × 108 1.67 × 109 100
Sephacryl S-1000 (PBS) 30 1.67 × 107 4.86 × 108 29
Hemolymph 7 8.30 × 107 5.81× 108 100
Sephacryl S-1000 (0.01% Triton X-100 in PBS) 30 1.66 × 107 4.98 × 108 86*
Hemolymph 7 3.33 × 108 2.33 × 108 100
Sephacryl S-1000 (0.1% Triton X-100 in PBS) 30 3.04 × 106 9.12 × 107 41
Hemolymph 7 2.38 × 108 1.67 × 109 100
Sephacryl S-1000 (0.01% Tween 20 in PBS) 30 2.29 × 107 6.87 × 108 41
* This purification protocol was repeated several times and typical result is shown.
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13 ng of hPRR with a correlation coefficient of 0.9869
(Figure 4B). Absorbance was higher for BmNPV-GFPuv-
hPRR than for BmNPV-CP--GGT2, indicating that
BmNPV-GFPuv-hPRR was displayed on the surface of
BmNPV particles (Figure 4C). Based on this result, 8.1
ng of GFPuv-hPRR was displayed on the surface of 260
ng of BmNPV-GFPuv-hPRR proteins and ~3.1% of total
proteins in BmNPV-GFPuv-hPRR was GFPuv-hPRR. This
value was similar to that calculated by densitometry
from the results of a Western blot (Figure 1; 2.7%).
Application of GFPuv-hPRR displaying BmNPV to protein-
protein interaction detection
Previously, Sakihama et al. reported that specific inter-
actions between CD2-displaying AcMNPV particles and
CD58-displaying AcMNPV particles could be detected
by ELISA and that baculovirus surface display technol-
ogy was therefore applicable to protein-protein interac-
tion detection [17]. The binding of hPRR to its ligand,
Figure 2 Treatment of purified BmNPV-GFPuv-hPRR particles
with each concentration of Triton X-100. Purified BmNPV-GFPuv-
hPRR particles were suspended with 0, 0.01, 0.1 or 1% of TritonX-
100, respectively and supernatant (1) and pellet (2) were separated
by ultracentrifugation. Proteins were separated by a 12% SDS-PAGE
gel and GFPuv-hPRR was detected by Western blot and CBB stain.
Figure 3 Proteinase K treatment of purified BmNPV-GFPuv-hPRR particles. Purified BmNPV-GFPuv-hPRR particles were suspended with either
0, 0.002, 0.02, 0.2 or 2 μg of proteinase K, respectively, and incubated at room temperature for 15 min. Proteins were separated by a 12% SDS-
PAGE gel and GFPuv-hPRR was detected by Western blot and CBB stain.
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Figure 4 Detection of hPRR by ELISA. (A) Illustration of Detection of hPRR by ELISA. For determination of immobilized hPRR (left), purified
hPRR were immobilized on a plate. And then, mouse anti-FLAG M2 antibody was incubated for binding hPRR and anti-FLAG M2 antibody. HRP-
conjugated anti-mouse IgG antibody was used for detection of binding hPRR and anti-FLAG M2 antibody. Based on this hPRR calibration curve,
the amount of displayed GFPuv-hPRR was determined (right). BmNPV-GFPuv-hPRR particles were immobilized on a plate. And then, mouse anti-
FLAG M2 antibody was incubated for binding hPRR and anti-FLAG M2 antibody. Detection of hPRR was carried out by HRP-conjugated anti-
mouse IgG antibody. (B) Calibration curve of purified hPRR by ELISA. (C) Detection of hPRR on the surface of BmNPV-GFPuv-hPRR particles. Closed
circles and closed squares denote purified BmNPV GFPuv-hPRR particles and purified BmNPV-CP
--GGT2 particles, respectively.
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human prorenin, was detected using BmNPV-GFPuv-
hPRR particles by ELISA. Human prorenin was immobi-
lized on the wells and then incubated with purified
BmNPV-GFPuv-hPRR particles (Figure 5A). GFPuv-hPRR
displaying on the surface of BmNPV particles bind to
human prorenin immobilized onto the plate, and then
are detected by ELISA using mouse anti-FLAG M2 and
HRP-conjugated anti-mouse IgG as primary and second-
ary antibodies (Figure 5B). Significant absorbance of
BmNPV-GFPuv-hPRR was detected compared to only a
buffer or BmNPV-CP--GGT2, which does not display
hPRR on its surface. This result indicates that BmNPV
surface display is applicable to protein-protein interac-
tion detection; in addition ELISAs based on this
BmNPV system could be used in the screening of hPRR
blockers.
Discussion
Baculovirus has been used widely for recombinant pro-
tein production, and recently as a surface display system.
Some transmembrane proteins are displayed on the
baculovirus surface without any fusion with the baculo-
virus envelope protein [15,16,26]. Baculoviruses that dis-
play transmembrane proteins on their surfaces are
suitable for use in ELISAs, for the expression cloning of
a gene from a cDNA library and for making proteolipo-
somes [17,27]. In particular, baculovirus particles can be
used as probes for the expression cloning of receptors
and ligands from cDNA libraries using magnetic sorting
and flowcytometric analysis [17]. This method enabled
the cloning of CD2 cDNA from a human T-cell cDNA
library using CD58 displaying AcMNPV particles.
Previously, we reported the production of high titers
of BmNPV displaying hPRR in silkworm larvae [8].
When the BmNPV-GFPuv-hPRR particles were purified
by Sephacryl S-1000 column chromatography without
using detergent, the recovery yield of particles was only
30% [8], which was similar to that of this work (Tables
1 and 2). In the current study, we were able to purify
hPRR-displaying BmNPV particles from the hemolymph
of silkworm larvae with high recovery in the presence of
0.01% Triton X-100 (Table 2). In the case of virus-like
particles (VLP), these can be stabilized and prevented
from aggregation and precipitation by using non-ionic
detergents and other compounds [28-30]. Our results
suggest that the high level of recovery of baculovirus
particles in the presence of Triton X-100 might result
from inhibition of particle aggregation by Triton X-100.
Moreover, non-ionic detergents can prevent the adsorp-
tion of protein to surfaces [31,32]. In our experiments,
the optimal use of a non-ionic detergent contributed the
high recovery of baculovirus particles. However, when a
higher-than-optimal amount of detergent was used
(>0.01%), the displayed protein was solubilized (Figure
2). These results suggest that the deleterious effect of
high detergent concentration during purification of
BmNPV-GFPuv-hPRR particles was caused by the loss of
envelope proteins on the surface of the particles. In
Table 1, although protein concentration of Triton X-
100-suspended fraction was the same as that of PBS-
suspended one, purity of Triton X-100-suspended
BmNPV particles and recovery ratio were 11% higher
than that of PBS-suspended ones. This suggests that the
presence of 0.01% Triton X-100 is effective for the puri-
fication of BmNPV particles from silkworm larval
hemolymph.
Aggregation is a major problem in the production,
purification and concentration of viruses [33,34]. It has
also been reported that virus instability is due to the
aggregation of virus particles, which results in their pre-
cipitation [35,36]. To obtain high titer of virus stocks,
viruses have to be concentrated. However, such high
titers are prone to aggregate during purification and
concentration steps. In the current study, we were able
to purify high titers of BmNPV particles displaying
hPRR from the hemolymph of silkworm larvae without
aggregation in the presence of 0.01% Triton X-100 and
to omit the concentration step. Silkworms can produce
higher titers of baculoviruses than cultured cells, Sf-9
and Sf-21 cells. The method of using silkworm larvae
and SEC in the presence of Triton X-100 is therefore
useful for the high-titer preparation of functional
BmNPV particles displaying heterogeneous transmem-
brane proteins or ligands.
In this study, ~3% of total proteins of BmNPV parti-
cles were displayed as GFPuv-hPRR. GP64 is a major
protein in the envelope of baculoviruses. The display of
heterogeneous proteins and peptides can be also
achieved by the fusion with GP64 [14,37-39]. More
hPRR can be displayed by the fusion with the trans-
membrane and cytoplasmic domains of GP64 than with
those of hPRR because of the abundance of GP64 in the
baculovirus envelope. The envelope glycoprotein of
human immunodeficiency virus (HIV) can be incorpo-
rated into HIV virus-like particles by the replacement of
its native transmembrane and cytoplasmic domains with
those of GP64 [39]. The cytoplasmic domain might be
important for incorporating the HIV envelope protein
into the lipid bilayer of envelope viruses and virus-like
particles and for it to stably reside in its envelope. The
cytoplasmic domain of the transmembrane domain
might be also important for displaying on the surface of
baculovirus particles.
Displaying GFPuv-hPRR on its surface was detected by
ELISA using mouse anti-FLAG M2 and HRP-conjugated
anti-mouse IgG antibodies without solubilization and
purification of hPRR. GFPuv-hPRR on the surface of
BmNPV particles was confirmed as an active form by
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Figure 5 Detection of binding of GFPuv-hPRR to human prorenin by ELISA. (A) Illustration of detection of binding of GFPuv-hPRR to human
prorenin by ELISA. In prorenin-hPRR binding detection experiment, human prorenin was immobilized on a plate. Approximately 3.5 × 106 pfu of
BmNPV particles were added into the plate and each well and this plate was incubated. Detection of BmNPV binding to human prorenin was
the same method as hPRR detection as shown in Figure 4. (B) Detection of binding of BmNPV-GFPuv-hPRR particles to human prorenin. Human
prorenin was immobilized in a 96-well plate and incubated together with BmNPV-GFPuv-hPRR particles. BmNPV-GFPuv-hPRR particles binding to
human prorenin were detected by ELISA. Closed circles, closed squares and open circles denote purified BmNPV GFPuv-hPRR particles, purified
BmNPV-CP--GGT2 particles and PBS (pH 6.2), respectively.
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binding to human prorenin immobilized onto the plate.
However, accuracy of ELISA was not high enough,
because of small difference of detected absorbance
between BmNPV-GFPuv-hPRR and negative control
(BmNPV-CP--GGT2). This ELISA can be improved by
using anti-GP64 antibody as a primary antibody because
GP64 is displayed on the surface of BmNPV particles
far more than GFPuv-hPRR. Moreover, this ELISA has
to be improved for more precise binding analysis. For
example, the activation of human prorenin by its bind-
ing to hPRR might be detected by immobilization of the
hPRR-displaying BmNPV particles onto the plate. This
ELISA is simple and convenient compared to previous
method [40] and a new ELISA for the analysis of hPRR
and hPRR blockers screening can be established based
on BmNPV surface display system.
Conclusion
We have shown here that the BmNPV surface display
system can be utilized in protein-protein interaction
detection. A large-scale production of BmNPV particles
can be performed using silkworm larvae and high titer
of BmNPV particles can be purified from hemolymph
using SEC with a high recovery ratio. This BmNPV-silk-
worm system could be used for the efficient and effec-
tive application of baculovirus particles as nanoparticles
because of the scale on which baculovirus particles can
be produced and the low cost and simple protocol of
that production.
Methods
Production and purification of recombinant BmNPV in
silkworm
A recombinant BmNPV, BmNPV-GFPuv-hPRR, was
constructed by using E. coli BmDH10bac [7] according
to a previous report [19]. A FLAG sequence was
inserted at the N-terminus of hPRR for detection with
Western blot and ELISA. A bombyxin signal sequence
was connected at the N-terminus of GFPuv for GFPuv-
hPRR to enter into the secretory pathway in the cells of
the host. BmNPV-CP--GGT2 was constructed according
to the protocol described in [24]. Fifth-instar silkworm
larvae were injected with 50 μl of a DMRIE-C (Invitro-
gen)-bacmid mixture. This mixture contained ~5 μg of
DNA (bacmid and helper plasmid). To obtain 10 ml of
hemolymph, 15 silkworm larvae were reared using an
artificial diet, Silkmate 2S (Nihon Nosan, Yokohama,
Japan). After rearing for 6-7 days in a 25°C-rearing
chamber, larval hemolymph was collected by cutting the
caudal leg of the larva in a tube containing 5 μl of 200
mM 1-phenyl-2-thiourea to prevent melanization, and
centrifuged at 9000 rpm for 10 min; the hemolymph
was kept at -80°C before use. For large-scale production
of BmNPV-GFPuv-hPRR, 100-fold diluted hemolymph
was injected into 15 silkworm larvae.
Purification of BmNPV-GFPuv-hPRR was performed
according to a previous report [8]. Recovered hemo-
lymph was centrifuged at 8000 × g and supernatant was
collected. The supernatant was then loaded onto a
Sephacryl S-1000 column (2.6 × 52 cm, GE Healthcare
UK Ltd., Buckinghamshire, HP7 9NA, UK) equilibrated
with phosphate-buffered saline (PBS, pH 6.2) with each
concentration of Triton X-100. Elution was performed
at 4°C and monitored by absorbance at 280 and 254
nm. Every 5 ml of the fraction was collected. To con-
centrate purified BmNPV, fractions containing BmNPV
particles were pooled and concentrated by ultracentrifu-
gation at 114000 × g with a 25% sucrose cushion (25%
sucrose in 5 mM NaCl and 10 mM EDTA). Particles
were suspended by a small volume of PBS (pH 6.2) with
each detergent.
Quantitative real-time PCR to determine the number of
baculovirus particles
Quantitative real-time PCR (Q-PCR) was performed
according to a previous report [8]. In brief, baculoviral
DNA was extracted by using a High Pure Viral Nucleic
Acid Kit (Roche Diagnostics K. K., Tokyo, Japan)
according to the manufacturer’s protocol. The titration
assay using Q-PCR was performed by Mx3000P system
(Stratagene, La Jolla, CA, USA) and analyzed by MxPro
software (Stratagene). The ie-1-specific primers, Bmie-1-
F (CCCGTAACGGACCTTGTGCTT) and Bmie-1-R
(TTATCGAGATTTATTTACATACAACAAG) were
used.
Treatment of BmNPV particles with Triton X-100 or
proteinase K
To treat with Triton X-100, purified BmNPV with PBS
(pH 6.2) was concentrated by ultracentrifugation and
then suspended with PBS containing each concentration
(0.01, 0.1 or 1%) of Triton X-100. Suspensions (8 μg of
proteins) were kept at 4°C for 16 hours and ultracentri-
fuged. The supernatant and pellet were collected sepa-
rately and sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) and Western blot were
then performed. To treat with proteinase K, purified
BmNPV with PBS (pH 6.2) was concentrated by ultra-
centrifugation and then suspended with PBS containing
0.01% Triton X-100. Each volume (0.002, 0.02, 0.2 and 2
μg) of proteinase K was added into 3 mg of BmNPV
protein and the mixture was incubated at room tem-
perature for 15 min. Proteins of BmNPV particles were
analyzed by using SDS-PAGE and Western blot.
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SDS-PAGE and Western blot
Proteins were separated by SDS-PAGE using 12% polya-
crylamide gels that were stained with Coomassie Brilli-
ant Blue (CBB) solution. In the case of Western blot,
proteins in gels were blotted onto a polyvinylidene
fluoride (PVDF) membrane using Mini Trans-Blot Elec-
trophoretic Transfer Cell (Bio-Rad, Hercules, CA, USA).
After being blocked in 5% skimmed milk in Tris-buf-
fered saline containing 0.1% Tween 20 (TBST), the
membrane was incubated in 1:10000 diluted mouse
anti-FLAG M2 antibody (Sigma-Aldrich, St. Louis, MO,
USA) for 1 hour. The membrane was washed with
TBST, and then incubated in 1:20 000 diluted anti-
mouse labeled with horseradish peroxidase (HRP) (GE
Healthcare) for 1 hour. Detection was performed using
ECL Plus Western blotting reagent (GE Healthcare.).
Specific bands were detected using a Fluor-S/MAX
multi-imager (Bio-Rad).
hPRR detection by ELISA
BmNPV particles and purified hPRR were incubated in a
96-well plate at 4°C with 0.1M carbonate buffer (pH 9.6)
for 16 hours to become immobilized on the plate. Wells
were washed with PBS (pH 7.4) containing 0.01%
Tween 20 (PBST) four times. Blocking buffer (PBST
containing 3% skimmed milk) was added into each well
and plates were incubated at room temperature for
1 hour. Wells were washed with PBS (pH 7.4) contain-
ing 0.01% Tween 20 (PBST) four times. Mouse anti-
FLAG M2 antibody diluted 1000-fold with Can Get Sig-
nal Solution I (TOYOBO, Co. Ltd., Tokyo) was added
into each well and the plates were incubated at room
temperature with moderately stirring in a 96 well plate
shaker (BioShaker V·BR-36, TAITEC, Saitama, Japan)
for 1 hour. After wells were washed with PBST four
times, HRP-conjugated anti-mouse IgG antibody diluted
5000-fold with PBST was added into each well and the
plates were incubated at room temperature with moder-
ately stirring in a 96 well plate shaker (BioShaker) for
1 hour. Wells were washed with PBST four times fol-
lowed by the HRP reaction. 100 μl of substrate [0.1-mg
ml-1 3,3’,5,5’-tetramethylbenzidine(TMBZ) in 100-mM
sodium acetate, pH 6.0, with 0.2% (v/v) of 30% hydrogen
peroxide] was added to each well and left at room tem-
perature for blue-color development. The reaction was
stopped by the addition of 50 μl of 1N H2SO4 solution.
The developed color was measured at optical densities
(ODs) of 450 nm and 655 nm. The value of OD655
minus OD450 was used as a measure of the amount of
hPRR. hPRR that was used as a hPRR standard was pur-
ified from insect cells expressing it with anti-FLAG M2
antibody agarose (Sigma-Aldrich Inc., St. Louis, MO,
USA) [25]
In the prorenin-hPRR binding detection experiment,
human prorenin was incubated in a 96-well plate at 4°C
with 50 mM phosphate buffer (pH 7.4) for 16 hours to
become immobilized on the plate. Wells were washed
with PBS (pH 7.4) containing 0.01% Tween 20 (PBST)
four times. Blocking buffer (PBST containing 3%
skimmed milk) was added into each well and plates
were incubated at room temperature for 1 hour. Wells
were washed with PBS T four times. Approximately
3.5 × 106 pfu of BmNPV particles were added into each
well and this plate was incubated at room temperature
with moderate stirring in a 96 well plate shaker (BioSha-
ker) for 3 hours. Wells were washed with PBST four
times. Detection of BmNPV binding to human prorenin
was done using the same method as for hPRR detection.
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